Open AccessRandomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study
Author(s) -
Masaomi Nangaku,
Hirotaka Takama,
Tomohiro Ichikawa,
Kazuya Mukai,
Masahiro Kojima,
Yusuke Suzuki,
Hirotaka Watada,
Takashi Wada,
Kohjiro Ueki,
Ichiei Narita,
Naoki Kashihara,
Takashi Kadowaki,
Hiroki Hase,
Tadao Akizawa
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac242
Subject(s) - medicine , renal function , placebo , kidney disease , dialysis , urology , clinical endpoint , heart failure , randomized controlled trial , creatinine , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom